Eton Pharmaceuticals Inc.

NASDAQ: ETON · Real-Time Price · USD
16.91
0.21 (1.26%)
At close: Aug 15, 2025, 3:30 PM

Eton Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
58.18M 48.33M 39.01M 34.68M 31.38M 34.3M 31.64M 32.83M 29.02M 24.38M 21.25M 18.85M 16.4M 12.11M 21.83M 15.82M 14.88M 11.84M
Cost of Revenue
23.62M 20.06M 15.6M 14.11M 12.71M 11.58M 10.58M 9.04M 7.61M 8.04M 6.8M 4.94M 4.36M 1.75M 2.62M 2.64M 2.17M 2.06M
Gross Profit
34.56M 28.27M 23.41M 20.57M 18.67M 22.72M 21.06M 23.79M 21.41M 16.34M 14.45M 13.9M 12.04M 10.36M 19.21M 13.18M 12.71M 9.78M
Operating Income
-807K -2.27M -2.6M -5.22M -6.28M 543K -1.19M 1.61M -736K -5.96M -8.51M -8.01M -10.96M -11.95M -1.5M -10.23M -10.65M -12.87M
Interest Income
n/a n/a n/a n/a n/a n/a n/a 150K 150K 150K 150K n/a n/a n/a n/a 2K 2K 2K
Pretax Income
-4.03M -4.5M -3.81M -5.31M -6.39M 1.16M -689K 2.23M -234K -6.35M -9.02M -8.89M -11.94M -12.4M -1.96M -10.68M -11.09M -13.8M
Net Income
-4.13M -4.58M -3.82M -5.48M -6.69M 913K -1.19M 1.98M -636K -6.75M -9.41M -9.29M -12.19M -12.64M -1.96M -10.68M -11.09M -13.8M
Selling & General & Admin
30.86M 26.77M 22.75M 20.61M 19.66M 18.74M 18.93M 18.71M 18.54M 19.13M 18.71M 18.18M 17.34M 15.34M 14.47M 14.45M 14.55M 14.21M
Research & Development
4.51M 3.77M 3.25M 5.17M 5.28M 3.44M 3.32M 3.22M 3.35M 2.91M 4M 3.73M 5.67M 6.97M 6.24M 8.96M 9.1M 8.72M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
35.37M 30.53M 26.01M 25.78M 24.94M 22.18M 22.25M 21.93M 21.89M 22.04M 22.71M 21.91M 23M 22.3M 20.7M 23.41M 23.66M 22.93M
Interest Expense
3.7M 2.56M 1.4M 293K 316K 388K 503K 537K 656K 750K 867K 886K 983K 1M 1.01M 1M 985K 940K
Selling & Marketing Expenses
n/a n/a n/a -1K -1K -1K -1K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
58.99M 50.59M 41.61M 39.9M 37.66M 33.76M 32.83M 30.96M 29.5M 30.09M 29.51M 26.85M 27.36M 24.06M 23.33M 26.05M 25.54M 24.7M
Income Tax Expense
101K 89K 15K 175K 301K 247K 499K 150K 300K 300K 291K 393K 247K 247K 4K 4K n/a n/a
Shares Outstanding (Basic)
26.89M 26.89M 26.14M 25.9M 25.78M 25.76M 25.74M 25.72M 25.59M 25.52M 25.38M 25.36M 25.13M 25.3M 25.29M 25.28M 25.2M 24.45M
Shares Outstanding (Diluted)
26.89M 26.89M 26.14M 26.55M 25.78M 25.76M 25.74M 25.72M 25.98M 25.52M 25.69M 25.36M 25.13M 25.3M 25.96M 25.28M 25.21M 26.55M
EPS (Basic)
-0.15 -0.18 -0.15 -0.21 -0.26 0.04 -0.04 0.09 -0.02 -0.26 -0.37 -0.37 -0.48 -0.5 -0.07 -0.43 -0.5 -0.65
EPS (Diluted)
-0.15 -0.18 -0.15 -0.22 -0.26 0.04 -0.04 0.09 -0.02 -0.26 -0.37 -0.37 -0.48 -0.5 -0.09 -0.45 -0.52 -0.67
EBITDA
19K -1.16M -1.24M -3.79M -4.93M 1.6M -168K 2.52M 151K -3.9M -6.49M -6.81M -9.85M -11.38M -953K -9.2M -9.54M -12.22M
EBIT
-460K -2.07M -2.4M -4.87M -5.93M 887K -847K 1.86M -484K -5.71M -8.26M -8.01M -10.96M -11.4M -949K -9.68M -10.11M -12.87M
Depreciation & Amortization
1.65M 1.93M 1.16M 1.08M 997K 929K 890K 867K 846K 1.81M 1.76M 1.65M 1.56M 472K 455K 482K 565K 644K